VRS
PACB icon

Virginia Retirement Systems’s Pacific Biosciences PACB Stock Holding History

Virginia Retirement Systems’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-28,200
Closed -$375K – 1007
2023
Q2 		$375K Buy
28,200
+14,200
+101% +$173K ﹤0.01% 790
2023
Q1 		$162K Buy
+14,000
New +$139K ﹤0.01% 974
2021
Q2 		– Sell
-16,400
Closed -$546K – 1111
2021
Q1 		$546K Buy
+16,400
New +$574K 0.01% 862

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Virginia Retirement Systems's PACB Position: Q3 2023 in Review

Virginia Retirement Systems sold out of Pacific Biosciences (PACB) in Q3 2023, closing a stake of 28,200 shares — an estimated $375K sold.

Virginia Retirement Systems first reported a position in PACB in Q1 2021 and held it in 3 quarters. The position peaked at $546K in Q1 2021. 274 funds tracked by Wall St. Rank hold PACB as of Q3 2023.

  • Virginia Retirement Systems reported no remaining Pacific Biosciences position as of Q3 2023 after selling out during the quarter.
  • Virginia Retirement Systems sold 28,200 Pacific Biosciences shares in Q3 2023, an estimated $375K.
  • Virginia Retirement Systems first reported a position in Pacific Biosciences in Q1 2021 and held it in 3 quarters.
  • Virginia Retirement Systems's Pacific Biosciences position peaked at $546K in Q1 2021.
  • 274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.